ESHRE 2022: DNA Technology Company at the 38th conference of the European Society for Human Reproduction and Embryology (ESHRE) in Milan

The 38th conference of the European Society for Human Reproduction and Embryology (ESHRE) was held in Milan from July 3-6, 2022. Almost 12,000 participants from 128 countries took part in the conference program and visited the exhibition.
The products presented at our booth have aroused the keen interest of many specialists from different countries.
According to our representative Dr. Manfred Koranda, the visitors paid special attention to our kits Androflor® and Femoflor® for quantitatively assessing the microbiota. The practice of using Femoflor ® 16 to determine and reduce the risk of premature birth was actively discussed.
Also the scientific program of the conference was very rich: 73 reports on the topics of genetics, reproductive medicine and embryology. Among others, reports were presented with the results of joint research work using Femoflor® and Androflor® kits. The research data were published in the Human Reproduction, Volume 37, Issue Supplement_1, July 2022;
The Microbiota Difference in Normal and Abnormal Semen Samples Assessed by Real-time RCR (by E Panacheva, E Plotko, D Zornikov, E Voroshilina)
The Vaginal Microbial Predictors of the Endometrial Microbiota (by D Zornikov, E Voroshilina, E Plotko, D Islamidi, E Abakumova, O Koposova)